- Home
- SOPH vs DRTS Comparison
SOPH vs DRTS Comparison
Compare SOPH & DRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SOPH
- DRTS
- Stock Information
- Founded
- SOPH 2011
- DRTS 2015
- Country
- SOPH Switzerland
- DRTS Israel
- Employees
- SOPH N/A
- DRTS N/A
- Industry
- SOPH Biotechnology: Biological Products (No Diagnostic Substances)
- DRTS Medical/Dental Instruments
- Sector
- SOPH Health Care
- DRTS Health Care
- Exchange
- SOPH Nasdaq
- DRTS Nasdaq
- Market Cap
- SOPH 214.9M
- DRTS 256.2M
- IPO Year
- SOPH 2021
- DRTS N/A
- Fundamental
- Price
- SOPH $3.46
- DRTS $3.28
- Analyst Decision
- SOPH Buy
- DRTS Strong Buy
- Analyst Count
- SOPH 1
- DRTS 1
- Target Price
- SOPH $7.00
- DRTS $9.00
- AVG Volume (30 Days)
- SOPH 88.9K
- DRTS 55.6K
- Earning Date
- SOPH 08-05-2025
- DRTS 08-11-2025
- Dividend Yield
- SOPH N/A
- DRTS N/A
- EPS Growth
- SOPH N/A
- DRTS N/A
- EPS
- SOPH N/A
- DRTS N/A
- Revenue
- SOPH $69,688,000.00
- DRTS N/A
- Revenue This Year
- SOPH $16.13
- DRTS N/A
- Revenue Next Year
- SOPH $23.80
- DRTS N/A
- P/E Ratio
- SOPH N/A
- DRTS N/A
- Revenue Growth
- SOPH 7.32
- DRTS N/A
- 52 Week Low
- SOPH $2.58
- DRTS $2.11
- 52 Week High
- SOPH $4.92
- DRTS $4.39
- Technical
- Relative Strength Index (RSI)
- SOPH 56.10
- DRTS 54.32
- Support Level
- SOPH $2.96
- DRTS $3.06
- Resistance Level
- SOPH $3.24
- DRTS $3.58
- Average True Range (ATR)
- SOPH 0.26
- DRTS 0.19
- MACD
- SOPH -0.00
- DRTS 0.02
- Stochastic Oscillator
- SOPH 84.53
- DRTS 57.75
About SOPH SOPHiA GENETICS SA
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.
About DRTS Alpha Tau Medical Ltd.
Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as localized radiation therapy for solid tumors. Its proprietary Alpha DaRT technology is designed to utilize the specific therapeutic properties of alpha particles while aiming to overcome, and even harness for potential benefit, the traditional shortcomings of alpha radiation's limited range. The company derives maximum revenue from Israel.